SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-23-004434
Filing Date
2023-02-09
Accepted
2023-02-09 16:58:59
Documents
2
Period of Report
2023-02-07

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1643
2 EX-24 DOCUMENT attachment1.htm EX-24 3056
  Complete submission text file 0000899243-23-004434.txt   6267
Mailing Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004
Business Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004 844-511-9056
Larimar Therapeutics, Inc. (Issuer) CIK: 0001374690 (see all company filings)

IRS No.: 203857670 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O LARIMAR THERAPEUTICS, INC. THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004
Business Address
Shankar Gopi (Reporting) CIK: 0001965014 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36510 | Film No.: 23607111